CONNEQT Health

CONNEQT Health’s mission is to increase longevity through medical technology advancements in vascular health. The company’s suite of products includes medical and home health devices and digital solutions for hypertension, cardiovascular disease and other vascular health disorders, based on its market-leading SphygmoCor vascular biomarker technology. CONNEQT Health is listed on the Australian Securities Exchange (ASX: CQT).

Founded in Sydney in 1994 by Dr Michael O’Rourke as ATCOR Medical, the company later traded as CardieX before adopting the CONNEQT Health name in September 2025. ABN 81 113 252 234.